Artemisinin Industry Research Report 2025

Summary

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

According to APO Research, The global Artemisinin market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Artemisinin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Artemisinin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Artemisinin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Artemisinin include , etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artemisinin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin.

The report will help the Artemisinin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Artemisinin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artemisinin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Artemisinin Segment by Company

Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource

Artemisinin Segment by Type

Extraction From Artemisia Annua
Semisynthetic Artemisinin

Artemisinin Segment by Application

Antimalarial Injections
Antimalarial Tablets

Artemisinin Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artemisinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artemisinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Artemisinin by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.2.2 Extraction From Artemisia Annua
2.2.3 Semisynthetic Artemisinin
2.3 Artemisinin by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Antimalarial Injections
2.3.3 Antimalarial Tablets
2.4 Global Market Growth Prospects
2.4.1 Global Artemisinin Production Value Estimates and Forecasts (2020-2031)
2.4.2 Global Artemisinin Production Capacity Estimates and Forecasts (2020-2031)
2.4.3 Global Artemisinin Production Estimates and Forecasts (2020-2031)
2.4.4 Global Artemisinin Market Average Price (2020-2031)
3 Market Competitive Landscape by Manufacturers
3.1 Global Artemisinin Production by Manufacturers (2020-2025)
3.2 Global Artemisinin Production Value by Manufacturers (2020-2025)
3.3 Global Artemisinin Average Price by Manufacturers (2020-2025)
3.4 Global Artemisinin Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Artemisinin Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Artemisinin Manufacturers, Product Type & Application
3.7 Global Artemisinin Manufacturers Established Date
3.8 Global Artemisinin Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Sanofi
4.1.1 Sanofi Artemisinin Company Information
4.1.2 Sanofi Artemisinin Business Overview
4.1.3 Sanofi Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.1.4 Sanofi Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 KPC Pharmaceuticals
4.2.1 KPC Pharmaceuticals Artemisinin Company Information
4.2.2 KPC Pharmaceuticals Artemisinin Business Overview
4.2.3 KPC Pharmaceuticals Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.2.4 KPC Pharmaceuticals Product Portfolio
4.2.5 KPC Pharmaceuticals Recent Developments
4.3 Kerui nanhai
4.3.1 Kerui nanhai Artemisinin Company Information
4.3.2 Kerui nanhai Artemisinin Business Overview
4.3.3 Kerui nanhai Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.3.4 Kerui nanhai Product Portfolio
4.3.5 Kerui nanhai Recent Developments
4.4 Guangxi xiancaotang
4.4.1 Guangxi xiancaotang Artemisinin Company Information
4.4.2 Guangxi xiancaotang Artemisinin Business Overview
4.4.3 Guangxi xiancaotang Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.4.4 Guangxi xiancaotang Product Portfolio
4.4.5 Guangxi xiancaotang Recent Developments
4.5 Guilin Pharmaceutical
4.5.1 Guilin Pharmaceutical Artemisinin Company Information
4.5.2 Guilin Pharmaceutical Artemisinin Business Overview
4.5.3 Guilin Pharmaceutical Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.5.4 Guilin Pharmaceutical Product Portfolio
4.5.5 Guilin Pharmaceutical Recent Developments
4.6 Natural Bio-engineering
4.6.1 Natural Bio-engineering Artemisinin Company Information
4.6.2 Natural Bio-engineering Artemisinin Business Overview
4.6.3 Natural Bio-engineering Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.6.4 Natural Bio-engineering Product Portfolio
4.6.5 Natural Bio-engineering Recent Developments
4.7 BIONEXX
4.7.1 BIONEXX Artemisinin Company Information
4.7.2 BIONEXX Artemisinin Business Overview
4.7.3 BIONEXX Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.7.4 BIONEXX Product Portfolio
4.7.5 BIONEXX Recent Developments
4.8 CAT KHANH
4.8.1 CAT KHANH Artemisinin Company Information
4.8.2 CAT KHANH Artemisinin Business Overview
4.8.3 CAT KHANH Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.8.4 CAT KHANH Product Portfolio
4.8.5 CAT KHANH Recent Developments
4.9 BEEPZ
4.9.1 BEEPZ Artemisinin Company Information
4.9.2 BEEPZ Artemisinin Business Overview
4.9.3 BEEPZ Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.9.4 BEEPZ Product Portfolio
4.9.5 BEEPZ Recent Developments
4.10 Novanat Bioresource
4.10.1 Novanat Bioresource Artemisinin Company Information
4.10.2 Novanat Bioresource Artemisinin Business Overview
4.10.3 Novanat Bioresource Artemisinin Production Capacity, Value and Gross Margin (2020-2025)
4.10.4 Novanat Bioresource Product Portfolio
4.10.5 Novanat Bioresource Recent Developments
5 Global Artemisinin Production by Region
5.1 Global Artemisinin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
5.2 Global Artemisinin Production by Region: 2020-2031
5.2.1 Global Artemisinin Production by Region: 2020-2025
5.2.2 Global Artemisinin Production Forecast by Region (2026-2031)
5.3 Global Artemisinin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
5.4 Global Artemisinin Production Value by Region: 2020-2031
5.4.1 Global Artemisinin Production Value by Region: 2020-2025
5.4.2 Global Artemisinin Production Value Forecast by Region (2026-2031)
5.5 Global Artemisinin Market Price Analysis by Region (2020-2025)
5.6 Global Artemisinin Production and Value, YOY Growth
5.6.1 North America Artemisinin Production Value Estimates and Forecasts (2020-2031)
5.6.2 Europe Artemisinin Production Value Estimates and Forecasts (2020-2031)
5.6.3 China Artemisinin Production Value Estimates and Forecasts (2020-2031)
5.6.4 Japan Artemisinin Production Value Estimates and Forecasts (2020-2031)
6 Global Artemisinin Consumption by Region
6.1 Global Artemisinin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
6.2 Global Artemisinin Consumption by Region (2020-2031)
6.2.1 Global Artemisinin Consumption by Region: 2020-2025
6.2.2 Global Artemisinin Forecasted Consumption by Region (2026-2031)
6.3 North America
6.3.1 North America Artemisinin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Artemisinin Consumption by Country (2020-2031)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Artemisinin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Artemisinin Consumption by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.4.8 Spain
6.4.9 Netherlands
6.4.10 Switzerland
6.4.11 Sweden
6.4.12 Poland
6.5 Asia Pacific
6.5.1 Asia Pacific Artemisinin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Artemisinin Consumption by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 India
6.5.7 Australia
6.5.8 Taiwan
6.5.9 Southeast Asia
6.6 South America, Middle East & Africa
6.6.1 South America, Middle East & Africa Artemisinin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East & Africa Artemisinin Consumption by Country (2020-2031)
6.6.3 Brazil
6.6.4 Argentina
6.6.5 Chile
6.6.6 Turkey
6.6.7 GCC Countries
7 Segment by Type
7.1 Global Artemisinin Production by Type (2020-2031)
7.1.1 Global Artemisinin Production by Type (2020-2031) & (MT)
7.1.2 Global Artemisinin Production Market Share by Type (2020-2031)
7.2 Global Artemisinin Production Value by Type (2020-2031)
7.2.1 Global Artemisinin Production Value by Type (2020-2031) & (US$ Million)
7.2.2 Global Artemisinin Production Value Market Share by Type (2020-2031)
7.3 Global Artemisinin Price by Type (2020-2031)
8 Segment by Application
8.1 Global Artemisinin Production by Application (2020-2031)
8.1.1 Global Artemisinin Production by Application (2020-2031) & (MT)
8.1.2 Global Artemisinin Production Market Share by Application (2020-2031)
8.2 Global Artemisinin Production Value by Application (2020-2031)
8.2.1 Global Artemisinin Production Value by Application (2020-2031) & (US$ Million)
8.2.2 Global Artemisinin Production Value Market Share by Application (2020-2031)
8.3 Global Artemisinin Price by Application (2020-2031)
9 Value Chain and Sales Channels Analysis of the Market
9.1 Artemisinin Value Chain Analysis
9.1.1 Artemisinin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Artemisinin Production Mode & Process
9.2 Artemisinin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Artemisinin Distributors
9.2.3 Artemisinin Customers
10 Global Artemisinin Analyzing Market Dynamics
10.1 Artemisinin Industry Trends
10.2 Artemisinin Industry Drivers
10.3 Artemisinin Industry Opportunities and Challenges
10.4 Artemisinin Industry Restraints
11 Report Conclusion
12 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings